MR evaluation of glioblastoma with triple-dose gadolinium-DO3A-butriol: Improved delineation of infiltrating tumour?;VERBESSERT DIE HOCHDOSISGABE EINES PARAMAGNETISCHEN KONTRASTMITTELS (GADOVIST) DIE DIAGNOSTISCHE AUSSAGE DER MAGNETRESONANZTOMOGRAPHIE BEI GLIOBLASTOMEN?

RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren

Volumn 164, Issue 2, 1996, Pages 119-125

  Hartmann, M ^a   Forsting, M ^a   Jansen, O ^a   Albert, F K ^b   Balzer, Th ^c   Sartor, K ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c BAYER PHARMA AG   (Germany)

Author keywords

Glioblastoma; High dose contrast media; Magnetic resonance

Indexed keywords

CONTRAST MEDIUM; GADOBUTROL; GADOLINIUM;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; GLIOBLASTOMA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GADOLINIUM; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; SUPRATENTORIAL NEOPLASMS;

EID: 0029940797     PISSN: 09366652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Albert, F. K., M. Forsting, K. Sartor, H. P. Adams, St. Kunze: Early postoperative MRI after resection of malignant glioma: Objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34 (1994) 45-61
2. Brant-Zawadzki, M., J. P. Badami, C. M. Mills, D. Norman, Th. Newton: Primary intracranial tumor imaging: a comparison of magnetic resonance and CT. Radiology 150 (1984) 435-440
3. Brant-Zawadzki, M., I. Berry, L. Osaki, R. Brasch, J. Murovic, D. Norman: Gd-DTPA in clinical MR of the brain: 1. Intraxial lesions. Amer. J. Neuroradiol. 7 (1986) 781-788
4. Burger, P. C., P. J. Dubois, S. C. Schold, K. R. Smith jr., G. L. Odom, D. C. Crafts, F. Giangaspero: Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J. Neurosurg. 58 (1983) 159-169
5. Burger, P. C., E. R. Heinz, T. Shibata, P. Kleihues: Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J. Neurosurg. 68 (1988) 698-704
6. Bradley, W. G., V. Waluch, R. A. Yadley, R. R. Wycoff: Comparison of CT and MR in 400 patients with suspected disease of the brain and cervical spinal cord. Radiology 152 (1984) 695-702
7. Bydder, G. M., R. E. Steiner: NMR imaging of the brain. Neuroradiology 23 (1982) 231-240
8. Carr, D. H., J. Brown, G. M. Bydder, R. E. Steiner, H. J. Weimann, U. Speck, A. S. Hall, I. R. Young: Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients. Amer. J. Roentgenol. 143 (1984) 215-224
9. Chang, K. H., D. G. Ra, M. H. Han, S. H. Cha, H. D. Kim, M. C. Han: Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T. Amer. J. Neuroradiol. 15 (1994) 1413-1419
10. Claussen, C., M. Laniado, E. Kazner, W. Schörner, R. Felix: Application of contrast agents in CT and MRI: their potential in imaging of brain tumors. Neuroradiology 27 (1985) 164-171
11. Elster, A. D.: Field-strength dependence of gadolinium enhancement: Theory and implications. Amer. J. Neuroradiol. 15 (1994) 1420-1423
12. Felix, R., W. Schörner, M. Laniado, H. P. Niendorf, C. Claussen, W. Fiegler, U. Speck: Brain Tumors: MR Imaging with Gd-DTPA. Radiology 156 (1985) 681-688
13. 1-weighted spin-echo images with use of magnetization L transfer. Radiology 190 (1994) 553-559
14. Forsting, M., F. K. Albert, St. Kunze, H. P. Adams, D. Zenner, K. Sartor: Extirpation of glioblastomas: MR and CT follow-up of residual tumor and regrowth patterns. Amer. J. Neuroradiol. 14 (1993) 77-87
15. Gado, M. H., M. L. E. Phelps, R. E. Coleman: An extravascular component of contrast enhancement in cranial computed tomography. Part I and II. Radiology 117 (1975) 589-593 and 595-597
16. Haustein, J., M. Laniado, H. P. Niendorf, Th. Hilbertz, J. Planitzer, W. Schörner, Th. Louton: Administration of gadopentate dimeglumine in MR imaging of intracranial tumors: dosage and field strength. Amer. J. Neuroradiol. 13 (1992) 1199-1206
17. Haustein, J., M. Laniado, H. P. Niendorf, Th. Louton, W. Beck, J. Planitzer, M. Schöffel, M. Reiser, W. Kaiser, W. Schörner, J. Hierholzer: Triple dose versus standard-dose gadopentate dimeglumine. A randomized study of 199 patients. Radiology 186 (1993) 855-860
18. Hochberg, F. H., A. Pruitt: Assumptions in radiotherapy of glioblastoma. Neurology 30 (1980) 907-911
19. Ito, U., H. J. Reulen, H. Tomita, J. Ikeda, J. Saito, T. Maehara: A computed tomography study on formation, propagation, and resolution of edema fluid in metastatic brain tumors. In: Long, D., et al.: Advances in neurology, Vol. 52 (1990) 459-468
20. Johnson, P. C., S. J. Hunt, B. P. Drayer: Human cerebral gliomas. Correlation of postmortem MR imaging and neuropathologic findings. Radiology 170 (1989) 211-217
21. Niendorf, H. P., J. Haustein, I. Cornelius, A. Alhassan, W. Clauss: Safety of Gd-DTPA: extended clinical experience. Magn. Res. Med. 22 (1991) 222-228
22. Ohnishi, T., N. Arita, T. Hayakawa, S. Izumoto, T. Taki, H. Yamamoto: Motility factor produced by malignant glioma cells: role in tumor invasion. J. Neurosurg. 73 (1990) 881-888
23. Runge, V. M, J. A. Clanton, A. C. Price, W. A. Herzer, J. H. Allen, C. L. Partain, A. E. James jr.: Evaluation of contrast enhanced MR imaging in a brain abscess model. Amer. J. Neuroradiol. 6 (1985) 325-327
24. Runge, V. M., D. Y. Gelblum, M. L. Pacetti, F. Carolan, G. Heard: Gd-HP-DO3A in clinical MR imaging of the brain. Radiology 177 (1990) 393-400
25. Scherer, H. J.: Cerebral astrocytomas and their derivates. The Amer. J. Canc. 40 (1940) 159-198
26. Wallner, K. E., J. H. Galicich, G. Krol, E. Arbit, M. G. Malkin: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int. J. Rad. Onc. Biol. Phys. 16 (1989) 1405-1409
27. Yuh, W. T. C., D. J. Fisher, J. D. Engelken, G. M. Greene, Y. Sato, T. J. Ryals, M. R. Crain, J. C. Ehrhardt: MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol. Radiology 180 (1991) 485-491
28. Yuh, W. T. C., J. D. Engelken, M. G. Muhonen, N. A. Mayr, D. J. Fisher, J. C. Ehrhardt: Experience with high-dose gadolinium MRI in the evaluation of brain metastases. Amer. J. Neuroradiol. 13 (1992) 335-345
29. Yuh, W. T. C., D. J. Fisher, V. M. Runge, S. W. Atlas, S. E. Harms, K. R. Maravilla, N. A. Mayr, J. E. Mollman, A. C. Price: Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases. Amer. J. Neuroradiol. 15 (1994) 1037-1051